shRNA-mediated Bmi-1 silencing sensitizes multiple myeloma cells to bortezomib

Author：

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.34, Iss.2, 2014-01, pp. : 616-623

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferation

International Journal of Molecular Medicine, Vol. 36, Iss. 5, 2015-01 ,pp. : 1393-1399

Spandidos Publications

Access to resources Recommend Favorite

Silencing Bmi-1 expression by RNA interference suppresses the growth of laryngeal carcinoma cells

International Journal of Molecular Medicine, Vol. 31, Iss. 5, 2013-01 ,pp. : 1262-1272

Spandidos Publications

Access to resources Recommend Favorite

Bortezomib-Induced Rhabdomyolysis in Multiple Myeloma

Acta Haematologica, Vol. 116, Iss. 3, 2006-10 ,pp. : 203-206

Karger

Access to resources Recommend Favorite

Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs

International Journal of Molecular Medicine, Vol. 29, Iss. 1, 2012-01 ,pp. : 102-106

Spandidos Publications

Access to resources Recommend Favorite

The effects of bortezomib on bone disease in patients with multiple myeloma

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 618-623

John Wiley & Sons Inc

Access to resources Recommend Favorite